This is not surprising considering the high estimated probability of receiving a false positive from one prostate-specific antigen (PSA) test (see Table 1) and the relatively frequent time interval for prostate cancer screening (see Fig 1 and S2 Table). This evidence concerns the gene KLK3 and prostate cancer.